ReviewDiseases (Basel, Switzerland)2024

Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn's Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies.

Andrea Pasta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.